Seroprevalence of Campylobacter Jejuni in Patients with Irritable Bowel Syndrome and in Healthy Individuals

Semnani, sh; Roshandel, GH; Faghih, H; Ghasemi kebria, F; Joshghani, H

Volume 7, Issue 4 (winter[PERSIAN] 2014) mljgoums 2014, 7(4): 85-89 | Back to browse issues page

Mendeley

Zotero

RefWorks

Semnani S, Roshandel G, Faghih H, Ghasemi kebria F, Joshghani H. Seroprevalence of Campylobacter Jejuni in Patients with Irritable Bowel Syndrome and in Healthy Individuals. mljgoums 2014; 7 (4) :85-89
URL: http://mlj.goums.ac.ir/article-1-349-en.html

Seroprevalence of Campylobacter Jejuni in Patients with Irritable Bowel Syndrome and in Healthy Individuals

Sh Semnani¹

, GH Roshandel²

, H Faghih³

, F Ghasemi kebria⁴

, H Joshghani⁵

1- Associate Professor of Gasteroentology, Golestan Research Center of Gastroenterology and Hepatology
2- PhD Student of Epidemiology, Golestan Research Center of Gastroenterology and Hepatology
3- General Practitioner, Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences
4- MSc of Microbiology, Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences , kebria_fgh62@yahoo.com
5- Associate professor of Biochemistry, Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences

Abstract: (13850 Views)

Abstract Background and Objective: The patients with Post-Infectious Irritable bowel syndrome (PI-IBS), a subtype of irritable bowel syndrome, suffer from bacterial gastroenteritis. Since campylobacter Jejuni (CJ) is one of the most common agents in this syndrome, we aimed to evaluate the prevalence of Campylobacter Jejuni in patients with Irritable Bowel Disease. Material and Methods: This case - control study was conducted on 160 patients divided into 2 equal groups of healthy and unhealthy. The presence of Anti- CJ antibody (IgG and IgA) was evaluated by ELISA and the comparison was performed by chi-square test. Results: The mean age of case (31.51) and control (31.84) was not statistically different (P = 0.87). Titer of Anti- Campylobacter Jejuni antibody IgG was positive in 25% of patients and 18.8% of the healthy ones (p=0.02). IgA Seropositivity in patients was 7.5% but no one in control group was positive (p =0.01) Conclusion: Seroprevalence of Cj in patients with IBS was higher significantly than that of control group. Thus, Cj can be known as one of the causes of Post-infection in patients with IBS in our region and it should be paid more attention in diagnostic assessment of these patients. Keyword: Irritable Bowel Syndrome Campylobacter Jejuni Antibody

Keywords: Irritable Bowel Syndrome, Campylobacter Jejuni, Antibody

Full-Text [PDF 713 kb] | Full Text (HTML) [English Abstract] (3040 Downloads)

Research Article: Brief Report |
Received: 2013/09/11 | Accepted: 2013/10/9 | Published: 2013/10/9 | ePublished: 2013/10/9